These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34843149)

  • 1. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
    Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
    Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
    Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
    Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Autoantibodies Associated with Basal-like Breast Cancers.
    Wang J; Figueroa JD; Wallstrom G; Barker K; Park JG; Demirkan G; Lissowska J; Anderson KS; Qiu J; LaBaer J
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1332-40. PubMed ID: 26070530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
    Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
    Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
    Fortner RT; Damms-Machado A; Kaaks R
    Gynecol Oncol; 2017 Nov; 147(2):465-480. PubMed ID: 28800944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer.
    Tabuchi Y; Shimoda M; Kagara N; Naoi Y; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2016 May; 157(1):55-63. PubMed ID: 27113738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer.
    Qiu C; Wang B; Wang P; Wang X; Ma Y; Dai L; Shi J; Wang K; Sun G; Ye H; Zhang J
    Cancer Sci; 2021 Aug; 112(8):3388-3400. PubMed ID: 34115421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
    Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
    Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
    PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody signature in hepatocellular carcinoma using seromics.
    Zhang S; Liu Y; Chen J; Shu H; Shen S; Li Y; Lu X; Cao X; Dong L; Shi J; Cao Y; Wang X; Zhou J; Liu Y; Chen L; Fan J; Ding G; Gao Q
    J Hematol Oncol; 2020 Jul; 13(1):85. PubMed ID: 32616055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
    Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.
    Anderson KS; Sibani S; Wallstrom G; Qiu J; Mendoza EA; Raphael J; Hainsworth E; Montor WR; Wong J; Park JG; Lokko N; Logvinenko T; Ramachandran N; Godwin AK; Marks J; Engstrom P; Labaer J
    J Proteome Res; 2011 Jan; 10(1):85-96. PubMed ID: 20977275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer.
    Wilson AL; Moffitt LR; Duffield N; Rainczuk A; Jobling TW; Plebanski M; Stephens AN
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):183-192. PubMed ID: 29141850
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of candidate serologic markers for type I and type II ovarian cancer.
    Lu D; Kuhn E; Bristow RE; Giuntoli RL; Kjær SK; Shih IeM; Roden RB
    Gynecol Oncol; 2011 Sep; 122(3):560-6. PubMed ID: 21704359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
    Schummer M; Thorpe J; Giraldez MD; Bergan L; Tewari M; Urban N
    PLoS One; 2015; 10(11):e0142911. PubMed ID: 26565788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
    Evans RL; Pottala JV; Egland KA
    Cancer Prev Res (Phila); 2014 May; 7(5):545-55. PubMed ID: 24641868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.
    Kaaks R; Fortner RT; Hüsing A; Barrdahl M; Hopper M; Johnson T; Tjønneland A; Hansen L; Overvad K; Fournier A; Boutron-Ruault MC; Kvaskoff M; Dossus L; Johansson M; Boeing H; Trichopoulou A; Benetou V; La Vecchia C; Sieri S; Mattiello A; Palli D; Tumino R; Matullo G; Onland-Moret NC; Gram IT; Weiderpass E; Sánchez MJ; Navarro Sanchez C; Duell EJ; Ardanaz E; Larranaga N; Lundin E; Idahl A; Jirström K; Nodin B; Travis RC; Riboli E; Merritt M; Aune D; Terry K; Cramer DW; Anderson KS
    Int J Cancer; 2018 Aug; 143(3):515-526. PubMed ID: 29473162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.